Please wait while we open this resource.
K
Clinical reviews
GLIFLOZINS IN THE MANAGEMENT OF CARDIOVASCULAR DISEASE
Brigham and Women’s Hospital, Harvard Medical School
PDF202211 pages3.0 MB
The article provides an in-depth analysis of the mechanisms by which SGLT2 inhibitors improve cardiovascular outcomes. It explores their effects on renal function, body weight, and various cardiovascular risk factors. The review also highlights clinical implications and potential adverse effects associated with these medications, emphasizing their importance in contemporary cardiovascular care.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
SURVIVAL AFTER INITIAL STRESS TESTING VS ANATOMIC TESTING IN SUSPECTED CORONARY ARTERY DISEASE
Same clinical topic · Cardiology
PRACTICAL CARDIO-ONCOLOGY
Same clinical topic · Cardiology
OXFORD CARDIOLOGY LIBRARY: Hypertension
Same clinical topic · Cardiology
CARDIAC INVOLVEMENT IN PARASITIC INFECTIONS
Same clinical topic · Cardiology
The Athlete’s ECG
Same clinical topic · Cardiology
Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review
Same clinical topic · Cardiology
Current ECG Aspects of Interatrial Block
Same clinical topic · Cardiology
Arrhythmic mitral valve prolapse in 2023: Evidence-based update
Same clinical topic · Cardiology
INTERPRETING THE NORMAL PACEMAKER
Same clinical topic · Cardiology